SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-220570"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-220570" > Nocturnal sweating ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003471naa a2200373 4500
001oai:DiVA.org:uu-220570
003SwePub
008140317s2013 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2205702 URI
0247 a https://doi.org/10.1136/bmjopen-2013-0027952 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Arnardottir, Erna Sif4 aut
2451 0a Nocturnal sweating - a common symptom of obstructive sleep apnoea :b the Icelandic sleep apnoea cohort
264 c 2013-05-14
264 1b BMJ,c 2013
338 a electronic2 rdacarrier
520 a Objectives: To estimate the prevalence and characteristics of frequent nocturnal sweating in obstructive sleep apnoea (OSA) patients compared with the general population and evaluate the possible changes with positive airway pressure (PAP) treatment. Nocturnal sweating can be very bothersome to the patient and bed partner. Design: Case-control and longitudinal cohort study. Setting: Landspitali-The National University Hospital, Iceland. Participants: The Icelandic Sleep Apnea Cohort consisted of 822 untreated patients with OSA, referred for treatment with PAP. Of these, 700 patients were also assessed at a 2-year follow-up. The control group consisted of 703 randomly selected subjects from the general population. Intervention: PAP therapy in the OSA cohort. Main outcome measures: Subjective reporting of nocturnal sweating on a frequency scale of 1-5: (1) never or very seldom, (2) less than once a week, (3) once to twice a week, (4) 3-5 times a week and (5) every night or almost every night. Full PAP treatment was defined objectively as the use for = 4 h/day and = 5 days/week. Results: Frequent nocturnal sweating (= 3x a week) was reported by 30.6% of male and 33.3% of female OSA patients compared with 9.3% of men and 12.4% of women in the general population (p<0.001). This difference remained significant after adjustment for demographic factors. Nocturnal sweating was related to younger age, cardiovascular disease, hypertension, sleepiness and insomnia symptoms. The prevalence of frequent nocturnal sweating decreased with full PAP treatment (from 33.2% to 11.5%, p<0.003 compared with the change in non-users). Conclusions: The prevalence of frequent nocturnal sweating was threefold higher in untreated OSA patients than in the general population and decreased to general population levels with successful PAP therapy. Practitioners should consider the possibility of OSA in their patients who complain of nocturnal sweating.
7001 a Janson, Christeru Uppsala universitet,Lungmedicin och allergologi4 aut0 (Swepub:uu)chrisjn
7001 a Bjornsdottir, Erla4 aut
7001 a Benediktsdottir, Bryndis4 aut
7001 a Juliusson, Sigurdur4 aut
7001 a Kuna, Samuel T.4 aut
7001 a Pack, Allan I.4 aut
7001 a Gislason, Thorarinn4 aut
7102 a Uppsala universitetb Lungmedicin och allergologi4 org
7730 t BMJ Opend : BMJg 3:5, s. e002795-q 3:5<e002795-x 2044-6055
8564 u https://uu.diva-portal.org/smash/get/diva2:706356/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 u https://bmjopen.bmj.com/content/3/5/e002795.full.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-220570
8564 8u https://doi.org/10.1136/bmjopen-2013-002795

Hitta via bibliotek

  • BMJ Open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy